IMARC Group, a leading market research company, has recently released a report titled “Contract Research Organization (CRO) Services Market Report by Type (Drug Discovery, Pre-Clinical, Clinical, and Others), Therapeutic Area (Oncology, Cardiology, Infectious Disease, Neurology, Immunological Disorders, Gastroenterology and Hepatology, and Others), End User (Pharmaceutical and Biotechnological Companies, Medical Device Companies, and Others), and Region 2024-2032”. The study provides a detailed analysis of the industry, including the global contract research organization CRO services market trends, share, size, and industry trends forecast. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
The global contract research organization CRO services market size reached US$ 70.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 159.1 Billion by 2032, exhibiting a growth rate (CAGR) of 9% during 2024-2032.
Global Contract Research Organization (CRO) Services Market Trends:
Recent innovations in technology, such as electronic data capture (EDC) systems, wearable devices, and telemedicine, which are making clinical trials more efficient and cost-effective, encouraging more companies to utilize CRO services, are boosting the market growth.
Additionally, the increasing complexity of regulatory requirements for drug approval processes, which encourages pharmaceutical companies to rely on CROs that have specialized knowledge and expertise in navigating these regulations, is propelling the market growth. Besides this, the significant growth in the development of biopharmaceuticals and biosimilars, leading to a higher demand for specialized services that CROs provide, including complex trial designs and advanced analytical testing, is contributing to the market growth.
Request to Get the Sample Report:
https://www.imarcgroup.com/contract-research-organization-services-market/requestsample
Factors Affecting the Growth of the Contract Research Organization (CRO) Services Industry:
- Increasing Research and Development (R&D) Expenditure by Pharmaceutical and Biotech Companies:
The pharmaceutical and biotechnology sectors are experiencing a surge in research and development (R&D) investments, primarily driven by the need to innovate and develop new therapies to address unmet medical needs. With the escalating cost and complexity of drug development, these companies are allocating significant resources to R&D to stay competitive. This trend is particularly evident in the push towards discovering novel drugs and biologics, which require extensive research efforts and rigorous clinical trials to ensure efficacy and safety.
However, maintaining in-house R&D capabilities can be prohibitively expensive, leading many firms to outsource their research activities to CROs. By leveraging CRO services, pharmaceutical and biotech companies can significantly reduce overhead costs associated with staffing, infrastructure, and technology while also gaining access to specialized expertise and global networks.
- Rising Prevalence of Chronic Diseases:
The increasing global burden of chronic diseases, such as cancer, diabetes, and cardiovascular disorders, is a major factor propelling the demand for CRO services. Chronic diseases are among the leading causes of mortality worldwide, necessitating continuous research into new treatments and therapies. As the prevalence of these conditions rises due to factors like increasing geriatric populations, lifestyle changes, and genetic predispositions, there is an urgent need for extensive clinical research to develop effective interventions. This scenario creates a robust pipeline of clinical trials, which in turn drives the demand for CRO services. CROs play a critical role in this process by managing and executing clinical trials efficiently, ensuring regulatory compliance, and optimizing patient recruitment and retention strategies.
Moreover, the complexity and specificity of research required for chronic diseases often demand specialized knowledge and advanced technological capabilities, which many CROs possess.
- Outsourcing of Clinical Trials:
Outsourcing clinical trials to CROs has become a prevalent strategy among pharmaceutical companies aiming to reduce costs, accelerate development timelines, and mitigate risks associated with drug development. Conducting clinical trials is a resource-intensive process that requires substantial financial investment, regulatory navigation, and logistical coordination across multiple sites and countries. By outsourcing these trials, pharmaceutical companies can capitalize on the expertise and infrastructure that CROs provide, which includes access to diverse patient populations, state-of-the-art data management systems, and experienced personnel. CROs specialize in managing all aspects of clinical trials, from protocol development and site selection to patient recruitment and data analysis, thereby allowing pharmaceutical companies to focus on their core competencies of drug discovery and commercialization.
Contract Research Organization (CRO) Services Market Report Segmentation:
By Type:
Drug Discovery
- Target Validation
- Lead Identification
- Lead Optimization
- Others
Pre-Clinical
Clinical
- Phase I Trial Services
- Phase II Trial Services
- Phase III Trial Services
- Phase IV Trial Services
Others
Clinical holds most of the market share as they are essential for regulatory approval and market entry.
By Therapeutic Area:
- Oncology
- Cardiology
- Infectious Disease
- Neurology
- Immunological Disorders
- Gastroenterology and Hepatology
- Others
Oncology accounted for the largest market share due to the high prevalence and complexity of cancer, driving significant investment in clinical trials and studies.
By End User:
- Pharmaceutical and Biotechnological Companies
- Medical Device Companies
- Others
Pharmaceutical and biotechnological companies represented the largest segment as they are the primary consumers of CRO services, relying heavily on outsourcing to manage the costs and complexities associated with drug development and clinical research.
Regional Insights:
- North America
- Asia Pacific
- Europe
- Latin America
- Middle East and Africa
North America’s dominance in the market is attributed to its well-established healthcare infrastructure, high R&D expenditure, and the presence of numerous pharmaceutical and biotechnology companies.
Competitive Landscape with Key Players:
The competitive landscape of the contract research organization CRO services market size has been studied in the report with the detailed profiles of the key players operating in the market.
Some of These Key Players Include:
- Charles River Laboratories International Inc.
- Covance Inc. (Laboratory Corporation of America Holdings)
- ICON Clinical Research Limited
- IQVIA Inc.
- Medpace Inc.
- Parexel International Corporation
- PPD Inc.
- PRA Health Sciences Inc.
- SGS SA
- Syneos Health Inc.
Ask Analyst for Customized Report:
https://www.imarcgroup.com/request?type=report&id=3493&flag=C
Key Highlights of the Report:
- Market Performance (2018-2023)
- Market Outlook (2024-2032)
- Market Trends
- Market Drivers and Success Factors
- Impact of COVID-19
- Value Chain Analysis
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
134 N 4th St
Brooklyn, NY 11249, USA
Website: imarcgroup.com
Email: [email protected]
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800
